Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation

Abstract

Caffeic acid phenethyl ester (CAPE) is a polyphenolic natural product that possesses numerous biological activities including anti-inflammatory effects. CAPE-mediated nuclear factor-erythroid 2 p45 (NF-E2)-related factor 2 (Nrf2) activation is likely responsible for some of its biological effects. CAPE was chemically modified to yield CAPE analogues that were subjected to experiments examining cellular Nrf2 activity. CAPE and the CAPE analogue with a catechol moiety, but not the other analogues, activated the Nrf2 pathway. In addition, only biotin-labeled CAPE analogues with the catechol moiety precipitated Kelch-like ECH associated protein 1 (Keap1) when incubated with cell lysates and streptavidin agarose beads. Sodium hypochlorite (NaOCl) oxidation of the catechol moiety in CAPE produced an oxidized, electrophilic form of CAPE (Oxi-CAPE) and greatly enhanced the ability of CAPE to activate Nrf2 and to bind to Keap1. Rectal administration of CAPE ameliorated 2,4,6-trinitrobenzene sulfonic acid-induced rat colitis and activated the Nrf2 pathway in the inflamed colon, and incubation of CAPE in the lumen of the inflamed distal colon generated Oxi-CAPE. However, these biological effects and chemical change of CAPE were not observed in the normal colon. Our data suggest that CAPE requires the catechol moiety for the oxidation-enhanced activation of the Nrf2 pathway and has potential as a pathologically targeted Nrf2-activating agent that is exclusively activated in pathological states with oxidative stress such as colonic inflammation.

Keywords: 2,4,6-Trinitrobenzene sulfonic acid; 3-phenylpropionic acid phenethyl ester; ARE; Antioxidant response element; BTCA; BTDHHC; BTDMC; Biotin-tagged caffeic acid; Biotin-tagged dihydroxydihydrocinnamic acid; Biotin-tagged dimethoxycinnamic acid; CAPE; Caffeic acid phenethyl ester; DHHC; DMC; DMHC; Dihydrohydroxycinnamic acid phenethyl ester; Dimethoxycinnamic acid phenethyl ester; Dimethoxydihydrocinnamic acid phenethyl ester; Electrophile; HBSS; Hank′s buffered salt solution; Keap1; Kelch-like ECH associated protein 1; MPO; Nrf2; Nuclear factor-erythroid 2 p45 (NF-E2)-related factor 2; Oxidation of catechol; PPAPE; Pathologically targeted therapeutic agent; Structural analysis; TNBS; myeloperoxidase.